Huntington’s Disease
-
Low-flow cerebrospinal fluid in Huntington’s disease: study
Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord. Read MoreSep 7, 2023
-
Huntington’s Disease Clinic lands Level 1 designation
The Vanderbilt University Medical Center (VUMC) Huntington’s Disease Clinic is one of only four in the nation to receive a Level 1 Center of Excellence designation. Read MoreAug 24, 2017
-
Compound developed at VUMC may delay Huntington’s disease
A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder. Read MoreOct 29, 2015
-
VUMC’s Huntington’s Disease Clinic recognized
Vanderbilt University Medical Center’s Huntington’s Disease Clinic has been named a 2015 Center of Excellence by the Huntington’s Disease Society of America (HDSA). Read MoreFeb 26, 2015
-
New tools to probe manganese biology
Vanderbilt researchers have developed tools to probe the role of the essential metal manganese in neurons, and which offer a started point for developing therapeutic agents for manganese-related neurological disorders. Read MoreNov 26, 2014
-
Clinic helps patients cope with Huntington’s disease
Melissa Darnall could easily look around her family reunions and pick out who had Huntington’s disease (HD). The genetic disorder had affected four of her five aunts and uncles and her father, and the balance problems and shakiness typical of HD were readily apparent in those siblings. Read MoreNov 21, 2013